Liangshan Mu

1.7k total citations · 1 hit paper
35 papers, 516 citations indexed

About

Liangshan Mu is a scholar working on Reproductive Medicine, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Liangshan Mu has authored 35 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Reproductive Medicine, 12 papers in Public Health, Environmental and Occupational Health and 8 papers in Molecular Biology. Recurrent topics in Liangshan Mu's work include Ovarian function and disorders (20 papers), Reproductive Biology and Fertility (11 papers) and Ovarian cancer diagnosis and treatment (5 papers). Liangshan Mu is often cited by papers focused on Ovarian function and disorders (20 papers), Reproductive Biology and Fertility (11 papers) and Ovarian cancer diagnosis and treatment (5 papers). Liangshan Mu collaborates with scholars based in China, Taiwan and Sweden. Liangshan Mu's co-authors include Yue Zhao, Jie Qiao, Xiaoting Sun, Haiyan Yang, Rong Li, Mixue Tu, Dan Zhang, Yu-Chen Lai, Zhenhong Ye and Jiexue Pan and has published in prestigious journals such as Science, Endocrine Reviews and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Liangshan Mu

32 papers receiving 506 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction

2024 53 citations Yang Liu, Jingjing Jiang et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Liangshan Mu China	14	288	175	132	64	60	35	516
Amanda B. Cress United States	13	328 1.1×	238 1.4×	98 0.7×	82 1.3×	87 1.4×	15	573
Israel Ortega Spain	12	297 1.0×	235 1.3×	85 0.6×	50 0.8×	85 1.4×	13	516
Anna Calik-Ksepka Poland	8	434 1.5×	264 1.5×	103 0.8×	76 1.2×	135 2.3×	8	633
Zhenteng Liu China	12	210 0.7×	120 0.7×	87 0.7×	23 0.4×	105 1.8×	24	392
Qiaohong Lai China	11	197 0.7×	164 0.9×	149 1.1×	17 0.3×	97 1.6×	17	426
Yiping Yu China	16	245 0.9×	282 1.6×	143 1.1×	29 0.5×	87 1.4×	43	601
M. Maggie United States	12	184 0.6×	294 1.7×	254 1.9×	48 0.8×	36 0.6×	14	606
Seyedeh Zahra Shahrokhi Iran	10	154 0.5×	99 0.6×	102 0.8×	33 0.5×	29 0.5×	19	333
Chisato Kunitomi Japan	14	319 1.1×	260 1.5×	139 1.1×	18 0.3×	74 1.2×	23	538

Countries citing papers authored by Liangshan Mu

Since Specialization

Citations

This map shows the geographic impact of Liangshan Mu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangshan Mu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangshan Mu more than expected).

Fields of papers citing papers by Liangshan Mu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangshan Mu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangshan Mu. The network helps show where Liangshan Mu may publish in the future.

Co-authorship network of co-authors of Liangshan Mu

This figure shows the co-authorship network connecting the top 25 collaborators of Liangshan Mu. A scholar is included among the top collaborators of Liangshan Mu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangshan Mu. Liangshan Mu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Fengyu, Ming Zhu, Guiquan Wang, et al.. (2025). Harnessing omics data for drug discovery and development in ovarian aging. Human Reproduction Update. 31(3). 240–268. 7 indexed citations

Wang, Guiquan, Yurong Zhang, Haiyan Yang, et al.. (2025). Multiomics and Systematic Analyses Reveal the Roles of Hemoglobin and the HIF‐1 Pathway in Polycystic Ovary Syndrome. Advanced Science. 12(14). e2411679–e2411679. 2 indexed citations

Wang, Guiquan, Haiyan Yang, Xintong Jiang, et al.. (2024). Association of serum uric acid with women’s ovarian reserve: observational study and Mendelian randomization analyses. Fertility and Sterility. 122(1). 162–173. 3 indexed citations

Liu, Yang, Jingjing Jiang, Liangshan Mu, et al.. (2024). Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction. Science. 384(6701). eadk5382–eadk5382. 53 indexed citations breakdown →

Wang, Lin, Liangshan Mu, Ye Yao, Jun Xu, & Xiaoting Zou. (2024). Application of Fluorescent Composite Materials as a Sustained Release System in Treatment of Polycystic Ovary Syndrome. Journal of Fluorescence. 35(7). 6161–6171.

Shen, Yanting, et al.. (2024). Unveiling the biological functions and therapeutic potentials of LONP1 in the ovary. Trends in Molecular Medicine. 31(6). 506–508.

Wang, Guiquan, Congying Wang, Hsun‐Ming Chang, et al.. (2024). Genetic and Epigenetic Landscape for Drug Development in Polycystic Ovary Syndrome. Endocrine Reviews. 45(4). 437–459. 14 indexed citations

Yan, Li, Wencheng Zhu, Yuchen Qian, et al.. (2024). Transcriptomic profiling of day 3 human embryos of poor quality reveals molecular links to divergent developmental trajectories. Cell Reports. 43(11). 114888–114888. 2 indexed citations

Liu, Yan, Meiyu Zhang, Alain Pumir, et al.. (2023). Multi-channel electrohysterography enabled uterine contraction characterization and its effect in delivery assessment. Computers in Biology and Medicine. 167. 107697–107697. 3 indexed citations

10.

Lin, Yiting, Guiquan Wang, Yan Li, et al.. (2023). Circulating Inflammatory Cytokines and Female Reproductive Diseases: A Mendelian Randomization Analysis. The Journal of Clinical Endocrinology & Metabolism. 108(12). 3154–3164. 13 indexed citations

11.

Mu, Liangshan, Zhenhong Ye, Yurong Zhang, et al.. (2023). PPM1K-regulated impaired catabolism of branched-chain amino acids orchestrates polycystic ovary syndrome. EBioMedicine. 89. 104492–104492. 32 indexed citations

12.

Wang, Congying, Wei Wu, Haiyan Yang, et al.. (2022). Mendelian randomization analyses for PCOS: evidence, opportunities, and challenges. Trends in Genetics. 38(5). 468–482. 43 indexed citations

13.

Hu, Kai-Lun, Zimiao Chen, Xiaoxue Li, et al.. (2022). Advances in clinical applications of kisspeptin-GnRH pathway in female reproduction. Reproductive Biology and Endocrinology. 20(1). 81–81. 21 indexed citations

14.

Hu, Kai-Lun, Zimiao Chen, Wenhai Deng, et al.. (2022). Diagnostic Value of Kisspeptin Levels on Early Pregnancy Outcome: a Systematic Review and Meta-analysis. Reproductive Sciences. 29(12). 3365–3372. 3 indexed citations

15.

Lai, Yu-Chen, Zhenhong Ye, Liangshan Mu, et al.. (2022). Elevated Levels of Follicular Fatty Acids Induce Ovarian Inflammation via ERK1/2 and Inflammasome Activation in PCOS. The Journal of Clinical Endocrinology & Metabolism. 107(8). 2307–2317. 41 indexed citations

16.

Wang, Siyu, Liangshan Mu, Chunmei Zhang, et al.. (2022). Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology. 13. 877807–877807. 28 indexed citations

17.

Mu, Liangshan, Xiaoting Sun, Mixue Tu, & Dan Zhang. (2021). Non-coding RNAs in polycystic ovary syndrome: a systematic review and meta-analysis. Reproductive Biology and Endocrinology. 19(1). 10–10. 70 indexed citations

18.

Mu, Liangshan, Yue Zhao, & Jie Qiao. (2018). Relationship between obesity and polycystic ovary syndrome and its potential mechanisms. 38(4). 343–349. 1 indexed citations

19.

Ding, Xiaohong, Lili Yang, Jian Wang, et al.. (2018). Subclinical Hypothyroidism in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 9. 700–700. 35 indexed citations

20.

Sun, Xiaoting, Lili Yang, Jiexue Pan, et al.. (2018). Age at menarche and the risk of gestational diabetes mellitus: a systematic review and meta-analysis. Endocrine. 61(2). 204–209. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact